1. Caramori ML, Repetto E, Perkins C, Pandey A, Rossing P. Cardio-Kidney-Metabolic Therapy Use Among Adults With Type 1 Diabetes and Chronic Kidney Disease. Diabetes Obes Metab. 2026 May;28(5):4344-4351.

2. Sartini C, Herrera R, Mazhar F, Torres ZA, Raluy M, Yates M, Yousif A, Younes R, Schattenberg JM. Metabolic dysfunction-associated steatohepatitis in the real world: clinical burden, disease progression, and risk stratification with non-invasive tests. BMC Gastroenterol. 2026 Mar 26;26(1):213.

3. Bhatt SP, Zhang Y, White J, Stanford RH, Mayen Herrera E, Cunoosamy D, Djandji M, Soliman M, Qureshi T, Subramaniam A. Characterization of Patients with COPD and GOLD E Classification in the United States. Int J Chron Obstruct Pulmon Dis. 2026 Mar 19;21:598962.

4. Greene SJ, Adam A, Schmedt N, Carlsen C, Brand M, Davies E, Jouaville Abrouk LS, Prochaska JH, Tran P, Alhamdow A. Contemporary Guideline‐Directed Medical Therapy for Heart Failure in the United States: The EMPACE Study. Journal of the American Heart Association. 2026 Mar 17;15(6):e044785.

5. Sánchez-Soliño O, Boroje I, Yue EX, Vinikoor-Imler L. Diagnosis patterns among diverse populations with mild cognitive impairment and Alzheimer's disease in the USA. JAR Life. 2026 Mar 5;15:100067.

6. Liang H, Huang S, Jiang Q, Zhang D, Guo D, Pinheiro SP. Development and Validation of Claims‐Based Algorithms for Non‐Melanoma Skin Cancer in Patients With Psoriasis Using Optum Market Clarity. Pharmacoepidemiology and Drug Safety. 2026 Mar;35(3):e70345.

7. Gibble TH, Huang A, Higgins C, Ananth M, Lee C, Ryder JR, Xue J. Clinical characteristics, treatment patterns, and healthcare utilization among children, adolescents, and young adults with obesity in the United States. Obesity Pillars. 2026 Feb 14:100252.

8. Vinikoor-Imler L, Yue EX, Boroje I, Sánchez-Soliño O. Comorbidities associated with mild cognitive impairment and Alzheimer's disease in the United States. Journal of Alzheimer’s Disease. 2026 Feb;109(4):1955-63.

9. Hartung HP, Atassi N, Alonso-Alonso M, Nunez M, Seluzhytsky A, Smolkina E, Dormont F, Lopez-Grancha M, Saeed O, Nguyen M, Lewis R. Characterizing Treatment Patterns and Healthcare Use in Patients and Subgroups with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Real-World Study. Neurology and Therapy. 2026 Feb;15(1):269-86.

10. Liang C, Zhou Y, Kent M, Chilson EL, Gessner BD, Begier E. Intensive Care Unit Stay and Mechanical Ventilation Among Adults with Respiratory Syncytial Virus-Related Hospitalization by Age and Comorbidity Status. Infectious Diseases and Therapy. 2026 Jan;15(1):101-15.

1. Castro AP, Alves AF, Piedade A, Clark LG, Bueno CC, Minowa E. Burden of Drug Waste in Oncology: Optimization of Resource Use. Value Health. 2014 Nov;17(7):A644.

2. Otávio Clark, Anna Flávia Alves, Ana Paula Castro, Fábio Santos, Eneas Faleiros, Luciana Clark, Luciano Paladini, Tobias Engel, Bruna Pegoretti. Budgetary impact of oral chemotherapy incorporation in Brazil: a real world data
analysis from the private payer perspective. J Bras Econ Saude. 2013;5(1):10-14.

3.Clark O, Faleiros EJ. Cost of the treatment of myelodisplastic syndrome in Brazil. Rev Bras Hematol Hemoter. 2011;33(1):31-4.

4. Clark L, Castro AP, Fortes AF, Santos F, Clark O, Engel T, Pegoretti B, Teich V, Vianna D, Puty F. Ideal vial size for bortezomib: real-world data on waste and cost reduction in treatment of multiple myeloma in Brazil. Value Health. 2011 Jul-Aug;14(5 Suppl 1):S82-4.
 

5. 7. Pegoretti Rosa B, Goes L, Moraes Z, Feijo L, Clark LGO. Newest target therapy and immunotherapy for the treatment of advanced melanoma: pattern of adoption by the private healthcare sector in Brazil. ISPOR USA; Boston: ISPOR;  VOLUME 20, ISSUE 9, PA881, OCTOBER 01, 2017.

6. O.A.C. Clark, L. Paladini, T. Engel, A. Caldas, J. Valentim. Costs of her 2 negative, hormonal receptor positive, metastatic breast cancer (MBC-HR+) treated with Everolimus (EVE) + Exemestane (EXE) in the Brazilian private system (BPS): a real world (RW) and published literature analysis. Value in Health Volume 16, Issue 7, Page A405, November 01, 2013.

7. Clark OAC, Paladini L, Engel T, Nishikawa AM, Borges L, Caldas A, Valentim J. Costs of her 2 negative, hormonal receptor positive, metastatic breast cancer (MBC-HNP) in Brazilian private market (BPM): a real world and published literature analysis. ISPOR 4th Latin America Conference.

1. Oxford MA, McLaughlin CM, McLaughlin CJ, Johnson TS, Roberts JM. Replacing the Scalpel With a Computer Mouse: An Evaluation of Time Spent on Electronic Health Record for Plastic Surgery Residents and Its Impact on Resident Training. Ann Plast Surg. 2024 Apr 1;92(4S Suppl 2):S271-S274.

2. Olopoenia A, Yamaguchi Y, Peeva E, Berman B, Jagun O, George P. Demographics, clinical characteristics, and treatment patterns among keloid patients: United States Electronic Health Records (EHR) Database Study. Int J Dermatol. 2024 Feb 27. doi: 10.1111/ijd.17099. Epub ahead of print. PMID: 38411301.

3. Chieh AY, Willis JG, Carroll CM, Mobley AA, Li Y, Li M, Woodard S. Why Start Now? Retrospective Study Evaluating Baseline Screening Mammography in Patients Age 60 and Older. Curr Probl Diagn Radiol. 2024 Jan-Feb;53(1):62-67.

4. Zhu G, Yuan A, Yu D, Zha A, Wu H. Machine learning to predict mortality for aneurysmal subarachnoid hemorrhage (aSAH) using a large nationwide EHR database. PLOS Digit Health. 2023 Dec 6;2(12):e0000400.

5. Ahlness EA, Orlander J, Brunner J, Cutrona SL, Kim B, Molloy-Paolillo BK, Rinne ST, Rucci J, Sayre G, Anderson E. "Everything's so Role-Specific": VA Employee Perspectives' on Electronic Health Record (EHR) Transition Implications for Roles and Responsibilities. J Gen Intern Med. 2023 Oct;38(Suppl 4):991-998.

6. Molloy-Paolillo B, Mohr D, Levy DR, Cutrona SL, Anderson E, Rucci J, Helfrich C, Sayre G, Rinne ST. Assessing Electronic Health Record (EHR) Use during a Major EHR Transition: An Innovative Mixed Methods Approach. J Gen Intern Med. 2023 Oct;38(Suppl 4):999-1006.

7. Scierka LE, Bradley BA, Glynn E, Davis S, Hoffman M, Tam-Williams JB, Mena-Hurtado C, Smolderen KG. Chronic Cough: Characterizing and Quantifying Burden in Adults Using a Nationwide Electronic Health Records Database. J Healthc Inform Res. 2023 Sep 27;8(1):50-64.

8. Shah NP, Peterson ED, Page C, Blanco R, Navar AM. Generalizability of an EHR-network dataset to the United States for cardiovascular disease conditions: Comparison of Cerner real world data with the national inpatient sample. Am Heart J. 2023 Sep;263:64-72.

9. Espinoza J, Tut M, Shah P, Kingsbury P, Nagaraj G, Meeker D, Bahroos N. Integrating REDCap patient-reported outcomes with the HealtheIntent population health platform: proof of concept. JAMIA Open. 2023 Aug 29;6(3):ooad074.

10. Sivasankar S, Goldman JL, Hoffman MA. Variation in antibiotic resistance patterns for children and adults treated at 166 non-affiliated US facilities using EHR data. JAC Antimicrob Resist. 2023 Jan 2;5(1):dlac128.